✦ LIBER ✦

The long-term efficacy and safety of new biological therapies for psoriasis

✍ Scribed by Kim A. Papp

Publisher: Springer-Verlag
Year: 2006
Tongue: English
Weight: 258 KB
Volume: 298
Category: Article
ISSN: 0340-3696
DOI: 10.1007/s00403-006-0660-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term efficacy and safety of tacalci

Long-term efficacy and safety of tacalcitol ointment in patients with chronic plaque psoriasis

✍ P.C.M. Van De Kerkhof; J. Berth-Jones; C.E.M. Griffiths; P.V. Harrison; H. Hönig 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB

The safety and efficacy of the use of me

The safety and efficacy of the use of methotrexate in long-term therapy for rheumatoid arthritis

✍ Joel M. Kremer; Joong Kil Lee 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 999 KB

Safe Psoriasis Control: A New Outcome Me

Safe Psoriasis Control: A New Outcome Measure for the Composite Assessment of the Efficacy and Safety of Psoriasis Treatment

✍ Kim A. Papp; Eric Henninger 📂 Article 📅 2005 🏛 Springer-Verlag 🌐 English ⚖ 204 KB

Persistent or recurrent acromegaly. Long

Persistent or recurrent acromegaly. Long-term endocrinologic efficacy and neurologic safety of postsurgical radiation therapy

✍ Thomas E. Goffman; Rahul Dewan; Richard Arakaki; Phillip Gorden; Edward H. Oldfi 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 393 KB 👁 2 views

The importance of disease associations a

The importance of disease associations and concomitant therapy for the long-term management of psoriasis patients

✍ Ulrich Mrowietz; James T. Elder; Jonathan Barker 📂 Article 📅 2006 🏛 Springer-Verlag 🌐 English ⚖ 527 KB

Efalizumab: Integrating a new biologic a

Efalizumab: Integrating a new biologic agent into the long-term management of moderate to severe plaque psoriasis

✍ Charles Lynde 📂 Article 📅 2005 🏛 Springer-Verlag 🌐 English ⚖ 122 KB